|
Dr. Rollman’s research focuses on developing novel interventions to treat mood and anxiety disorders in primary care and cardiac settings. He has been principal investigator on six NIH-funded R01 clinical trials including the Online Treatment for Mood and Anxiety Disorders Trial that evaluated the impact of providing computerized cognitive behavioral therapy and an Internet support group into a collaborative care program for treating depression and anxiety in primary care (Rollman BL, et al., JAMA Psychiatry, 2018); and the Hopeful Heart Trial that tested the effectiveness of a “blended" collaborative care model for treating both heart failure and depression (Rollman BL, et al., JAMA Internal Medicine, 2021).
Dr. Rollman has published over 100 scientific papers, including first-authored papers in the New England Journal of Medicine and the Journal of the American Medical Association, and has 4 U.S. patents. In addition to directing the Center for Behavioral Health, Media, and Technology, he is recent past-president of the American Psychosomatic Society whose goals are to advance the scientific study of biological, psychological, behavioral and social factors in health and disease (www.psychosomatic.org), and co-chair of the 11'th Scientific Meeting of the International Society for Research on Internet Interventions scheduled to take place on the Pitt campus in September 2022 (www.isrii2022pittsburgh.org). As a result of these and other projects and over 25 years of primary care practice, Dr. Rollman has become highly experienced with state-of-the-art techniques for treating mood and anxiety disorders in non-psychiatric settings, mental health services research, and has established an international network of collaborators to inform his work.
|